Hu Xuyang, Liang Jiaru, Hao Wenjian, Zhou Jiaqi, Gao Yuling, Gong Xiaoyang, Liu Yong
Department of Rehabilitation Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
Institute (College) of Integrative Medicine, Dalian Medical University, Dalian, China.
Front Neurol. 2023 Jun 8;14:1174711. doi: 10.3389/fneur.2023.1174711. eCollection 2023.
Acute ischemic stroke (AIS) is a primary cause of death and disability worldwide. Four markers that can be readily determined from peripheral blood, namely, the systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and total bilirubin, were measured in this study. We examined the relationship between the SII and in-hospital mortality after AIS and evaluated which of the above four indicators was most accurate for predicting in-hospital mortality after AIS.
We selected patients from the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database who were aged >18 years and who were diagnosed with AIS on admission. We collected the patients' baseline characteristics, including various clinical and laboratory data. To investigate the relationship between the SII and in-hospital mortality in patients with AIS, we employed the generalized additive model (GAM). Differences in in-hospital mortality between the groups were summarized by the Kaplan-Meier survival analysis and the log-rank test. The receiver operating characteristic (ROC) curve analysis was used to assess the accuracy of the four indicators (SII, NLR, PLR, and total bilirubin) for predicting in-hospital mortality in patients with AIS.
The study included 463 patients, and the in-hospital mortality rate was 12.31%. The GAM analysis showed a positive correlation between the SII and in-hospital mortality in patients with AIS, but the correlation was not linear. Unadjusted Cox regression identified a link between a high SII and an increased probability of in-hospital mortality. We also found that patients with an SII of >1,232 (Q2 group) had a considerably higher chance of in-hospital mortality than those with a low SII (Q1 group). The Kaplan-Meier analysis demonstrated that patients with an elevated SII had a significantly lower chance of surviving their hospital stay than those with a low SII. According to the results of the ROC curve analysis, the in-hospital mortality of patients with AIS predicted by the SII had an area under the ROC curve of 0.65, which revealed that the SII had a better discriminative ability than the NLR, PLR, and total bilirubin.
The in-hospital mortality of patients with AIS and the SII were positively correlated, but not linearly. A high SII was associated with a worse prognosis in patients with AIS. The SII had a modest level of discrimination for forecasting in-hospital mortality. The SII was slightly better than the NLR and significantly better than the PLR and total bilirubin for predicting in-hospital mortality in patients with AIS.
急性缺血性卒中(AIS)是全球范围内死亡和残疾的主要原因。本研究测量了可从外周血中轻松测定的四个标志物,即全身免疫炎症指数(SII)、中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)和总胆红素。我们研究了AIS后SII与住院死亡率之间的关系,并评估上述四个指标中哪一个对预测AIS后住院死亡率最准确。
我们从重症监护医学信息数据库-IV(MIMIC-IV)中选取年龄>18岁且入院时诊断为AIS的患者。我们收集了患者的基线特征,包括各种临床和实验室数据。为了研究AIS患者中SII与住院死亡率之间的关系,我们采用了广义相加模型(GAM)。通过Kaplan-Meier生存分析和对数秩检验总结各组间住院死亡率的差异。受试者工作特征(ROC)曲线分析用于评估四个指标(SII、NLR、PLR和总胆红素)对预测AIS患者住院死亡率的准确性。
该研究纳入了463例患者,住院死亡率为12.31%。GAM分析显示AIS患者中SII与住院死亡率呈正相关,但并非线性相关。未调整的Cox回归确定高SII与住院死亡率增加之间存在关联。我们还发现,SII>1232的患者(Q2组)住院死亡率明显高于SII低的患者(Q1组)。Kaplan-Meier分析表明,SII升高的患者住院存活几率明显低于SII低的患者。根据ROC曲线分析结果,SII预测的AIS患者住院死亡率的ROC曲线下面积为0.65,这表明SII的判别能力优于NLR、PLR和总胆红素。
AIS患者的住院死亡率与SII呈正相关,但并非线性相关。高SII与AIS患者预后较差相关。SII对预测住院死亡率有一定程度的判别能力。在预测AIS患者住院死亡率方面,SII略优于NLR,明显优于PLR和总胆红素。